Damian J Denson1, Paige M Padgett, Nicole Pitts, Gabriela Paz-Bailey, Trista Bingham, Juli-Ann Carlos, Pamela McCann, Nikhil Prachand, Jan Risser, Teresa Finlayson. 1. *Division of HIV/AIDS Prevention, NCHHSTP, CDC, Atlanta, GA; †Department of Management, Policy and Community Health, University of Texas School of Public Health, Houston, TX; ‡Health, Research, Informatics, and Technology Division, ICF International, Atlanta, GA; §Division of HIV and STD Programs, Los Angeles County Department of Public Health, Los Angeles, CA; ‖Office of LGBT Health, STI/HIV/AIDS Division, Chicago Department of Public Health, Chicago, IL; ¶STI/HIV/AIDS Division, Chicago Department of Public Health, Chicago, IL; and #Department of Epidemiology and Disease Control, University of Texas School of Public Health, Houston, TX.
Abstract
PURPOSE: HIV prevalence estimates among transgender women in the United States are high, particularly among racial/ethnic minorities. Despite increased HIV risk and evidence of racial disparities in HIV prevalence among transgender women, few data are available to inform HIV prevention efforts. METHODS: A transgender HIV-related behavioral survey conducted in 2009 in 3 US metropolitan areas (Chicago, Houston, and Los Angeles County), used respondent-driven sampling to recruit 227 black (n = 139) and Latina (n = 88) transgender women. We present descriptive statistics on sociodemographic, health care, and HIV-risk behaviors. RESULTS: Of 227 transgender women enrolled, most were economically and socially disadvantaged: 73% had an annual income of less than $15,000; 62% lacked health insurance; 61% were unemployed; and 46% reported being homeless in the past 12 months. Most (80%) had visited a health care provider and over half (58%) had tested for HIV in the past 12 months. Twenty-nine percent of those who reported having an HIV test in the past 24 months self-reported being HIV positive. Most of the sample reported hormone use (67%) in the past 12 months and most hormone use was under clinical supervision (70%). Forty-nine percent reported condomless anal sex in the past 12 months and 16% reported ever injecting drugs. CONCLUSION: These findings reveal the socioeconomic challenges and behavioral risks often associated with high HIV risk reported by black and Latina transgender women. Despite low health insurance coverage, the results suggest opportunities to engage transgender women in HIV prevention and care given their high reported frequency of accessing health care providers.
PURPOSE: HIV prevalence estimates among transgender women in the United States are high, particularly among racial/ethnic minorities. Despite increased HIV risk and evidence of racial disparities in HIV prevalence among transgender women, few data are available to inform HIV prevention efforts. METHODS: A transgender HIV-related behavioral survey conducted in 2009 in 3 US metropolitan areas (Chicago, Houston, and Los Angeles County), used respondent-driven sampling to recruit 227 black (n = 139) and Latina (n = 88) transgender women. We present descriptive statistics on sociodemographic, health care, and HIV-risk behaviors. RESULTS: Of 227 transgender women enrolled, most were economically and socially disadvantaged: 73% had an annual income of less than $15,000; 62% lacked health insurance; 61% were unemployed; and 46% reported being homeless in the past 12 months. Most (80%) had visited a health care provider and over half (58%) had tested for HIV in the past 12 months. Twenty-nine percent of those who reported having an HIV test in the past 24 months self-reported being HIV positive. Most of the sample reported hormone use (67%) in the past 12 months and most hormone use was under clinical supervision (70%). Forty-nine percent reported condomless anal sex in the past 12 months and 16% reported ever injecting drugs. CONCLUSION: These findings reveal the socioeconomic challenges and behavioral risks often associated with high HIV risk reported by black and Latina transgender women. Despite low health insurance coverage, the results suggest opportunities to engage transgender women in HIV prevention and care given their high reported frequency of accessing health care providers.
Authors: Larry Nuttbrock; Walter Bockting; Andrew Rosenblum; Sel Hwahng; Mona Mason; Monica Macri; Jeffrey Becker Journal: Am J Public Health Date: 2012-06-14 Impact factor: 9.308
Authors: Walter O Bockting; Michael H Miner; Rebecca E Swinburne Romine; Autumn Hamilton; Eli Coleman Journal: Am J Public Health Date: 2013-03-14 Impact factor: 9.308
Authors: Erin C Wilson; Robert Garofalo; Robert D Harris; Amy Herrick; Miguel Martinez; Jaime Martinez; Marvin Belzer Journal: AIDS Behav Date: 2009-02-06
Authors: Gregory Phillips Ii; David J McCuskey; Dylan Felt; Anand B Raman; Christina S Hayford; Jim Pickett; Julia Shenkman; Peter T Lindeman; Brian Mustanski Journal: Soc Sci Med Date: 2020-11-04 Impact factor: 4.634
Authors: Roberto L Abreu; Kirsten A Gonzalez; Della V Mosley; Lex Pulice-Farrow; Alissa Adam; Francesco Duberli Journal: Int J Transgend Health Date: 2020-06-02
Authors: Denton Callander; Byoungjun Kim; Micah Domingo; Loni Philip Tabb; Asa Radix; Liadh Timmins; Amir Baradaran; Michael B Clark; Dustin T Duncan Journal: Transgend Health Date: 2022-08-01
Authors: Trisha L Amboree; Jane R Montealegre; Paige Padgett Wermuth; Osaro Mgbere; Kayo Fujimoto; Charles Darkoh Journal: Prev Med Rep Date: 2022-06-10
Authors: Leigh A Bukowski; Cristian J Chandler; Stephanie L Creasy; Derrick D Matthews; Mackey R Friedman; Ronald D Stall Journal: J Acquir Immune Defic Syndr Date: 2018-12-01 Impact factor: 3.731
Authors: Cristian J Chandler; Stephanie L Creasy; Brian J Adams; Lisa A Eaton; Leigh A Bukowski; James E Egan; M Reuel Friedman; Ronald D Stall; Darren L Whitfield Journal: AIDS Behav Date: 2021-02-19
Authors: Alíxida G Ramos-Pibernus; Eliut R Rivera-Segarra; Sheilla L Rodríguez-Madera; Nelson Varas-Díaz; Mark Padilla Journal: Transgend Health Date: 2020-12-11